U.S.-listed shares of the company, which accepted the health
regulator's findings, were down about 25% at $2.39 before the
opening bell.
The company said Heath Canada's rating was based on observations
made during an inspection completed between July 10 and July 16,
and noted that five rooms, converted from operational areas,
were used for storage since June 2018 without prior approval by
the regulator.
The regulator also noted that two new areas were constructed
without prior approval and that security controls as well as
quality assurance investigations were inadequate at the
facility, while operating procedures did not to meet
requirements.
Documents and information were also not retained in a manner to
enable Health Canada to complete its audit in a timely manner.
Last month, Health Canada placed on hold about 5,200 kilograms
of dried cannabis harvested in five unlicensed rooms. CannTrust
also put a voluntary hold on 7,500 kg of inventory made in the
rooms.
CannTrust, which was notified of the non-compliance on Friday,
said it had already begun investigating and remediating the root
causes of any non-compliance and expects to propose a robust
remediation plan to Health Canada.
(Reporting by Arundhati Sarkar in Bengaluru; Editing by Bernard
Orr)
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|